Intelligent Bio Solutions Inc. (INBS) vs Xenetic Biosciences, Inc. (XBIO)

A side-by-side comparison of Intelligent Bio Solutions Inc. and Xenetic Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INBS vs XBIO

growth of $100 · dividends reinvested · last 6y
INBS -100.0% (-80.0%/yr)XBIO -87.8% (-29.6%/yr)XBIO compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $100202120222023202420252026$0$12
INBS XBIO

INBS vs XBIO: by the numbers

  • •INBS is the larger company ($5M vs $5M market cap).
  • •Both run net losses; XBIO's is the smaller (-75.90% vs -294.91% net margin).
  • •XBIO grew revenue faster over the past five years (34.31% vs 19.95% CAGR).

Metrics side by side

Valuation

MetricINBSXBIO
P/S ratio1.241.49
P/B ratio0.950.80

Profitability

MetricINBSXBIO
Gross margin48.63%100.00%
Operating margin-305.03%-95.23%
Net margin-294.91%-75.90%
ROE-225.57%-40.76%
ROIC-179.58%-43.50%

Growth (annualized)

MetricINBSXBIO
Revenue CAGR (5Y)19.95%34.31%
Total return CAGR (5Y)-80.26%-34.54%

Frequently asked

Which has grown faster, INBS or XBIO?
Over the past five years, XBIO grew revenue faster — INBS at a 19.95% CAGR versus XBIO at 34.31%.
How have INBS and XBIO total returns compared?
Over the past 5 years, INBS delivered -80.26% and XBIO delivered -34.54% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.